{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:22:33Z","timestamp":1773534153163,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":5084,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1093\/annonc\/mdj063","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T01:34:03Z","timestamp":1132709643000},"page":"29-34","source":"Crossref","is-referenced-by-count":48,"title":["Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group"],"prefix":"10.1016","volume":"17","author":[{"given":"A.","family":"Jatoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Nikcevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.R.","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Knost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.R.","family":"Fitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"K.M.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdj063_bb0010","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1200\/JCO.2004.11.069","article-title":"XELOX: Active first-line therapy for patients with metastatic colorectal cancer","volume":"22","author":"Cassidy","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj063_bb0015","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1200\/JCO.2003.09.016","article-title":"Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"21","author":"Scheithauer","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj063_bb0020","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1200\/JCO.2002.07.087","article-title":"Phase II study of capecitabine and oxaliplatin in first-line and second-line treatment of advanced or metastatic colorectal cancer","volume":"20","author":"Borner","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj063_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1385\/IJGC:35:2:103","article-title":"A phase II study of capecitabine plus oxaliplatin: a new first-line option in metastatic colorectal cancer","volume":"35","author":"Makatsoris","year":"2005","journal-title":"Int J Gastrointestinal Cancer"},{"key":"10.1093\/annonc\/mdj063_bb0030","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/annonc\/mdh343","article-title":"A phase II trial of capecitabine in previously untreated patients with advanced and\/or metastatic gastric cancer","volume":"15","author":"Hong","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdj063_bb0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000069313","article-title":"A pilot phase II study of capecitabine in advanced or recurrent gastric cancer","volume":"64","author":"Koizumi","year":"2003","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdj063_bb0040","first-page":"299","article-title":"Oxaliplatin and capecitabine as second line chemotherapy in patients with advanced gastric cancer","volume":"22","author":"Petrovic","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdj063_bb0045","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/sj.bjc.6602573","article-title":"A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid as first-line treatment of advanced gastric cancer patients","volume":"92","author":"De Vita","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdj063_bb0050","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/annonc\/mdf065","article-title":"Capecitabine in combination with oxaliplatin: a phase I dose, escalation study in patients with advanced or metastatic solid tumors","volume":"13","author":"Diaz-Rubio","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdj063_bb0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1442-2050.2004.00428.x","article-title":"Investigating four \u2018myths\u2019 surrounding dysphagia in patients with metastatic esophageal cancer: a multi-institutional study from the North Central Cancer Treatment Group","volume":"17","author":"Jatoi","year":"2004","journal-title":"Dis Esophagus"},{"key":"10.1093\/annonc\/mdj063_bb0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11136-004-0622-4","article-title":"A prospective comparison of quality of life measures for patients with esophageal cancer","volume":"14","author":"Blazeby","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1093\/annonc\/mdj063_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2307\/2531951","article-title":"Confidence intervals for a binomial parameter based on multi-stage tests","volume":"43","author":"Duffy","year":"1987","journal-title":"Biometrics"},{"key":"10.1093\/annonc\/mdj063_bb0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419403499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419403499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/17\/1\/29\/381059\/mdj063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T12:25:23Z","timestamp":1582201523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419403499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0923753419403499"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdj063","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}